Avoid deferred/intermittent treatment.

Higher QoL self-efficacy associated with better adherence.

No additional birth defects observed vs non-EFV- or non-ART-exposed infants.

MPs and peers are calling on Public Health Minister Steve Brine to urgently expand access to PrEP in England as Impact Trial turns patients away

Data favor single-tablet vs multitablet regimens.

Rates remain roughly 3-fold higher than in the general population.

Patient education sorely needed.

Healthcare professionals should promote the U = U message at all stages of care, says BHIVA

Some apparent modest associations not robust on sensitivity analyses.

Updates include new information on breastfeeding and more emphasis on psychosocial care; plus first guideline on pre-exposure prophylaxis

The UK has become one of the first countries to hit the UN’s 90-90-90 target, but 8000 people are still unaware of their infection

Despite major advances in medical knowledge of the infection and in disease management, HIV still remains a big challenge worldwide, with its greatest burden in Africa.

Types other than HPV‐16/18 appear to have greater effect among women aged 30 and older.